(Q43612447)

English

Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus

scientific article published on 23 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Fabio Mangiacapra

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Emanuele Barbato

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Germano Di Sciascio

object named as

Germano Di Sciascio

8

0 references

object named as

William Wijns

9

0 references

Bernard De Bruyne

7

object named as

Bernard De Bruyne

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Elisabetta Ricottini

6

object named as

Elisabetta Ricottini

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Laura Gatto

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

23 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

348-356

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

The platelet in diabetes: focus on prevention of ischemic events

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Universal definition of myocardial infarction

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Interven

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Platelet function monitoring in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Platelet inhibition by insulin is absent in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patien

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial dama

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.824562

21 January 2018

Identifiers

10.3109/09537104.2013.824562

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43612447&oldid=2172143294"